查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2028 年内皮功能障碍市场预测 - 按原因、测试类型和最终用户进行的全球分析
市场调查报告书
商品编码
1347168

2028 年内皮功能障碍市场预测 - 按原因、测试类型和最终用户进行的全球分析

Endothelial Dysfunction Market Forecast to 2028 - Global Analysis by Cause, Test Type, and End User
出版日期: | 出版商: The Insight Partners | 英文 198 Pages | 订单完成后即时交付

价格

2022年全球内皮功能障碍市场规模为19.9517亿美元，预计到2028年将达到25.8484亿美元；预计2022年至2028年该市场的复合年增长率为4.4%。市场增长归因于心血管疾病发病率的上升以及高胆固醇、糖尿病和肥胖症发病率的上升。

根据世界卫生组织 (WHO) 的数据，心血管疾病 (CVD) 是全球主要死亡原因之一，每年约有 3000 万人中风。 CVD包括脑血管疾病、冠心病、风湿性心脏病和冠状动脉疾病(CAD)。 CAD是所有心血管疾病中最常见的疾病，其特征是脂质和免疫细胞在冠状动脉内皮下间隙积聚或动脉粥样硬化。它涉及血管内皮的炎症反应。 CAD的特征是由于动脉粥样硬化导致冠状动脉管腔变窄、痉挛或阻塞而导致心肌缺血、缺氧或坏死。它已成为全世界死亡的主要原因。根据美国疾病控制与预防中心 (CDC) 的数据，美国有超过 6000 万女性 (44%) 患有某种形式的心脏病。心脏病是美国女性死亡的主要原因，可以影响任何年龄段的女性。 2021年，它造成了310,661名女性死亡，即近五分之一的女性死亡。新德里国家心臟研究所首席执行官兼首席心臟外科医生O. Yadava 博士在一篇题为“年轻印度人患冠状动脉疾病的风险较高”的文章中指出，当前的科学证据显示了令人震惊的结果；印度人的 CAD 发病率比任何其他族裔高出惊人的 50-400%。过去三十年来，西方 CAD 的患病率下降了一半。然而，印度的利率已经翻倍，并且没有下降的迹象。

根据美国心臟协会的数据，美国几乎一半的成年人患有某种类型的心血管疾病。预计到2035 年，将有超过1.3 亿人（即美国人口的45.1%）患有某种类型的心血管疾病。根据欧洲心脏病学会的报告，心血管疾病在欧洲导致390 万人死亡，在欧洲造成超过180 万人死亡。欧盟（EU）。简而言之，他们占欧洲所有死亡人数的 45%。过去25年来，欧洲CVD病例和新发CVD病例的绝对数量有所增加。由于男性吸烟习惯和酗酒率，中欧和西欧心血管危险因素的患病率很高。每年有超过 400 万欧洲人死于心血管疾病，主要是冠状动脉疾病 (CHD) 和中风。根据 Biosense Webster 2019 年发布的报告《超越负担：心房颤动对亚太地区的影响》，亚太地区有超过 1600 万人患有心房颤动，预计到 2050 年这一数字将达到约 7200 万人报告还表明，中老年人群更容易出现这种情况。

根据世界心臟联合会的数据，心血管疾病是中东和北非地区的首要死因，占所有死亡人数的三分之一以上，即每年 140 万人。此外，过去30年CVD死亡人数增加了48%，分别占阿曼和索马里死亡人数的40%和10%。 2021年，中东和北非地区年龄标准化CVD死亡率为每10万人134.2至600.2。

因此，心血管疾病的高患病率可能会推动内皮功能障碍市场的增长。

基于产品的见解

内皮功能障碍市场根据原因分为高血压、糖尿病、高胆固醇血症、白塞病、肥胖等。高血压细分市场在 2022 年占据最大市场份额。然而，预计糖尿病细分市场在 2022 年至 2028 年期间的复合年增长率最高，为 4.6%。心血管并发症是糖尿病引起的慢性血管并发症的结果。许多研究文章表明胰岛素抵抗与内皮功能障碍之间存在联繫。然而，目前尚不清楚糖尿病如何影响内皮细胞。糖尿病与微血管病变的风险直接相关，例如动脉粥样硬化性疾病、视网膜病变、肾病和神经病变。因此，患有糖尿病的患者患心血管疾病的风险呈指数增加。根据MDPI 期刊2020 年5 月发表的研究文章“糖尿病中的内皮功能障碍”，患有糖尿病前期疾病（例如空腹血糖受损(IFG) 和糖耐量受损(IGT)）的患者也显示出越来越多的证据表明内皮功能障碍与一个事件。考虑到上述因素，内皮功能障碍治疗的需求预计将呈指数级增长。

基于原因的见解

根据病因，内皮功能障碍市场分为高血压、糖尿病、高胆固醇血症、白塞氏病、肥胖等。 2022 年，高血压是最大的内皮功能障碍市场份额持有者。预计 2022 年至 2028 年，糖尿病领域的复合年增长率最高。

基于最终用户的见解

根据最终用户，内皮功能障碍市场分为医院、诊断中心、诊所等。医院是 2022 年最大的市场份额持有者，预计 2022 年至 2028 年復合年增长率最高。

此外，全世界患有糖尿病的人数正在广泛增长。根据国际糖尿病联盟（IDF）的预测，到2045年，糖尿病患者人数将从2020年的4.25亿增加到6亿。因此，糖尿病患者数量的增加推动了糖尿病领域内皮功能障碍市场的增长。

目录

第 1 章：简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场区隔
    • 全球内皮功能障碍市场 - 按原因
    • 全球内皮功能障碍市场 - 按测试类型
    • 全球内皮功能障碍市场 - 按最终用户分类
    • 全球内皮功能障碍市场 - 按地理位置

第 2 章：内皮功能障碍市场 - 要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：内皮功能障碍市场 - 市场格局

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 欧洲PEST分析
    • 亚太地区 PEST 分析
    • 中东和非洲 PEST 分析
    • 南美洲和中美洲 PEST 分析
  • 专家意见

第 5 章：内皮功能障碍市场 - 主要市场动态

  • 市场驱动因素
    • 心血管疾病发病率增加
    • 高胆固醇、糖尿病和肥胖症的发病率上升
  • 市场限制
    • 内皮功能障碍筛查技术的缺点
  • 市场机会
    • 新型生物标誌物和治疗策略的使用不断增加
  • 未来的趋势
    • 使用无创方法评估内皮功能障碍
  • 影响分析

第 6 章：内皮功能障碍市场 - 全球分析

  • 全球内皮功能障碍市场收入预测与分析
  • 全球内皮功能障碍市场（按地理位置）-预测与分析
  • 关键参与者的市场定位

第 7 章：内皮功能障碍市场分析 - 按原因

  • 概述
  • 内皮功能障碍市场，按原因划分，2022 年和 2028 年 (%)
  • 高血压
  • 糖尿病
  • 高胆固醇血症
  • 白塞病
  • 肥胖
  • 其他的

第 8 章：内皮功能障碍市场分析 - 按测试类型

  • 概述
  • 内皮功能障碍市场，按测试类型，2022 年和 2028 年 (%)
  • 侵入性测试
  • 非侵入性测试

第 9 章：内皮功能障碍市场分析 - 按最终用户

  • 概述
  • 内皮功能障碍市场，按最终用户划分，2022 年和 2028 年 (%)
  • 医院
  • 诊断中心
  • 诊所
  • 其他的

第 10 章：内皮功能障碍市场 - 2028 年收入和预测 - 地理分析

  • 北美
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：COVID-19 大流行对内皮功能障碍市场的影响

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

第 12 章：内皮功能障碍市场-行业格局

  • 概述
  • 内皮功能障碍市场的增长策略
  • 无机增长策略
    • 概述
  • 有机增长策略
    • 概述

第 13 章：公司简介

  • ZOLL Medical Corp
  • Sphingo Tec GmbH
  • Lawrence Berkeley National Laboratory
  • The Polymath Co
  • Endothelix Inc
  • Perimed AB
  • SMART Medical Ltd
  • Everist Health Inc
  • Alam Medical SaRl
  • Medizinische Messtechnik GmbH

第 14 章：附录

  • 关于 Insight Partners
  • 专业术语
Product Code: TIPRE00011290

The global endothelial dysfunction market size was valued at US$ 1,995.17 million in 2022 and is expected to reach a value of US$ 2,584.84 million by 2028; the market is estimated to record a CAGR of 4.4% from 2022 to 2028. The market growth is attributed to increasing incidence of cardiovascular diseases and rising incidence of high cholesterol, diabetes, and obesity.

According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are among the leading causes of death worldwide, and ~30 million people experience a stroke each year. CVDs include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and coronary artery disease (CAD). CAD is the most common disease among all cardiovascular diseases, and it is characterized by the accumulation of lipids and immune cells in the subendothelial space of the coronary arteries or atherosclerosis. It involves the inflammatory response of the vascular endothelium. CAD is characterized by ischemia, hypoxia, or necrosis of the myocardium resulting from narrowing, spasm, or obstruction of the coronary artery lumen by atherosclerosis. It has become the leading cause of death worldwide. According to the Centers for Disease Control and Prevention (CDC), over 60 million women (44%) in the US suffer from some form of heart disease. Heart disease is the leading cause of death among women in the US and can affect women of any age. In 2021, it caused 310,661 deaths among women, i.e., nearly one in five female deaths. According to an article entitled "Young Indians Are at Higher Risk of Coronary Artery Disease," by Dr. O. Yadava, C.E.O. & Chief Cardiac Surgeon, National Heart Institute, New Delhi, current scientific evidence shows alarming results; CAD rates among Indians are staggering 50-400% higher than any other ethnic group. The prevalence of CAD in the West has fallen by half over the past three decades. However, the rates in India have doubled, and there is no sign of a decline.

According to the American Heart Association, almost half of all adults in the US suffer from a type of CVD. Over 130 million people, i.e., 45.1% of the US population, are projected to suffer from a type of CVD by 2035. According to reports by the European Society of Cardiology, CVDs cause 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). In short, they account for 45% of all deaths in Europe. Over the past 25 years, the absolute number of CVD cases and new CVD cases have increased in Europe. There is a high prevalence of cardiovascular risk factors in Central and Western Europe owing to smoking habits and heavy drinking rates among men. More than 4 million Europeans die yearly from cardiovascular diseases mainly due to coronary artery disease (CHD) and stroke. As per the report "Beyond the Burden: The Impact of Atrial Fibrillation in Asia Pacific," by Biosense Webster, published in 2019, more than 16 million people in Asia Pacific suffer from atrial fibrillation, which is expected to reach ~72 million by 2050. The report also suggests that the middle-aged and elderly population is more prone to develop this condition.

According to the World Heart Federation, cardiovascular disease is the primary cause of death in the Middle East & North Africa, accounting for more than a third of all deaths or 1.4 million people annually. Further, CVD deaths have increased by 48% over the past 30 years, which accounted for 40% and 10% of deaths in Oman and Somalia, respectively. In 2021, age-standardized CVD mortality rates in the Middle East & North Africa ranged from 134.2 to 600.2 per 100,000 people.

Therefore, the high prevalence of cardiovascular diseases is likely to drive the endothelial dysfunction market growth.

Product-Based Insights

The endothelial dysfunction market, based on cause, is segmented into hypertension, diabetes, hypercholestrolaemia, Bechet's disease, obesity, and others. The hypertension segment held the largest share of the market in 2022. However, diabetes segment is anticipated to register the highest CAGR of 4.6% in the market during 2022-2028. Cardiovascular complications are the results of chronic vascular complications caused by diabetes. Many research articles have shown links between insulin resistance and endothelial dysfunction. However, it is still not understood how diabetes affects endothelium. Diabetes is directly related to risks of microvascular pathologies, such as atherosclerotic diseases, retinopathy, nephropathy, and neuropathy. Thus, the risk of cardiovascular disease increases exponentially in patients suffering from diabetes. According to the research article 'Endothelial Dysfunction in Diabetes,' published in May 2020 by MDPI journals, patients with prediabetic conditions, such as impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), also show accumulating evidence that implicates endothelial dysfunction as an event. Considering the above-listed factors, the demand for endothelial dysfunction treatment is estimated to increase exponentially.

Cause-Based Insights

Based on cause, the endothelial dysfunction market is segmented into hypertension, diabetes, hypercholestrolaemia, Bechet's disease, obesity, and others. Hypertension was the largest endothelial dysfunction market share holder in 2022. The diabetes segment is anticipated to register the highest CAGR from 2022 to 2028.

End User-Based Insights

Based on end user, the endothelial dysfunction market is categorized into hospitals, diagnostic centers, clinics, and others. Hospitals was the largest market share holder in 2022 and is anticipated to register the highest CAGR from 2022 to 2028.

Further, the number of people with diabetes is growing widely worldwide. According to the International Diabetes Federation (IDF), by 2045, the number of people with diabetes will rise to 600 million from 425 million in 2020. Thus, the growing number of diabetic people drives the endothelial dysfunction market growth for the diabetes segment.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the endothelial dysfunction market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global endothelial dysfunction market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the endothelial dysfunction market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Endothelial Dysfunction Market - by Cause
    • 1.3.2 Global Endothelial Dysfunction Market - by Test Type
    • 1.3.3 Global Endothelial Dysfunction Market - by End User
    • 1.3.4 Global Endothelial Dysfunction Market - by Geography

2. Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Endothelial Dysfunction Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Expert Opinion

5. Endothelial Dysfunction Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of Cardiovascular Diseases
    • 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
  • 5.2 Market Restraints
    • 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
  • 5.3 Market Opportunities
    • 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
  • 5.4 Future Trends
    • 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
  • 5.5 Impact Analysis

6. Endothelial Dysfunction Market - Global Analysis

  • 6.1 Global Endothelial Dysfunction Market Revenue Forecast and Analysis
  • 6.2 Global Endothelial Dysfunction Market, by Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Endothelial Dysfunction Market Analysis - by Cause

  • 7.1 Overview
  • 7.2 Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
  • 7.3 Hypertension
    • 7.3.1 Overview
    • 7.3.2 Hypertension: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Diabetes
    • 7.4.1 Overview
    • 7.4.2 Diabetes: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Hypercholestrolaemia
    • 7.5.1 Overview
    • 7.5.2 Hypercholestrolaemia: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Behcet's Disease
    • 7.6.1 Overview
    • 7.6.2 Behcet's Disease: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Obesity
    • 7.7.1 Overview
    • 7.7.2 Obesity: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. Endothelial Dysfunction Market Analysis - by Test Type

  • 8.1 Overview
  • 8.2 Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
  • 8.3 Invasive Tests
    • 8.3.1 Overview
    • 8.3.2 Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Non-Invasive Tests
    • 8.4.1 Overview
    • 8.4.2 Non-Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Flow Mediated Dilatory
      • 8.4.3.1 Overview
      • 8.4.3.2 Flow Mediated Dilatory: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.4 Venous Occlusion Plethysmography
      • 8.4.4.1 Overview
      • 8.4.4.2 Venous Occlusion Plethysmography: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.5 Peripheral Arterial Tonometry (PAT)
      • 8.4.5.1 Overview
      • 8.4.5.2 Peripheral Arterial Tonometry (PAT): Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.6 Circulating Markers
      • 8.4.6.1 Overview
      • 8.4.6.2 Circulating Markers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.7 Others
      • 8.4.7.1 Overview
      • 8.4.7.2 Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. Endothelial Dysfunction Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Diagnostics Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostics Centers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Clinics
    • 9.5.1 Overview
    • 9.5.2 Clinics: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 10.1 North America: Endothelial Dysfunction Market
    • 10.1.1 Overview
    • 10.1.2 North America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.1.3 North America: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    • 10.1.4 North America: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
      • 10.1.4.1 North America: Endothelial Dysfunction Market, by Non-Invasive Tests- 2020-2028 (US$ Million)
    • 10.1.5 North America: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.5.1 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.1.1 Overview
        • 10.1.5.1.2 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.1.3 US: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.5.1.4 US: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.5.1.4.1 US: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.1.5 US: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.5.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.2.1 Overview
        • 10.1.5.2.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.2.3 Canada: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.5.2.4 Canada: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.5.2.4.1 Canada: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.2.5 Canada: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.5.3 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.3.1 Overview
        • 10.1.5.3.2 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.3.3 Mexico: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.5.3.4 Mexico: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.5.3.4.1 Mexico: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.3.5 Mexico: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  • 10.2 Europe: Endothelial Dysfunction Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.2.3 Europe: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    • 10.2.4 Europe: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
      • 10.2.4.1 Europe: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.5 Europe: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.2.5.1 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.1.1 Overview
        • 10.2.5.1.2 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.1.3 Germany: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.2.5.1.4 Germany: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.2.5.1.4.1 Germany: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.1.5 Germany: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.2.5.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.2.1 Overview
        • 10.2.5.2.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.2.3 UK: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.2.5.2.4 UK: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.2.5.2.4.1 UK: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.2.5 UK: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.2.5.3 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.3.1 Overview
        • 10.2.5.3.2 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.3.3 France: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.2.5.3.4 France: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.2.5.3.4.1 France: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.3.5 France: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.2.5.4 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.4.1 Overview
        • 10.2.5.4.2 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.4.3 Italy: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.2.5.4.4 Italy: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.2.5.4.4.1 Italy: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.4.5 Italy: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.2.5.5 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.5.1 Overview
        • 10.2.5.5.2 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.5.3 Spain: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.2.5.5.4 Spain: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.2.5.5.4.1 Spain: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.5.5 Spain: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.2.5.6 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.6.1 Overview
        • 10.2.5.6.2 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.6.3 Rest of Europe: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.2.5.6.4 Rest of Europe: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.2.5.6.4.1 Rest of Europe: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.6.5 Rest of Europe: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  • 10.3 Asia Pacific: Endothelial Dysfunction Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.3.3 Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
      • 10.3.4.1 Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    • 10.3.5 Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.3.5.1 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.1.1 Overview
        • 10.3.5.1.2 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.1.3 China: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.3.5.1.4 China: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.3.5.1.4.1 China: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.3.5.1.5 China: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.3.5.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.2.1 Overview
        • 10.3.5.2.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.2.3 Japan: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.3.5.2.4 Japan: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.3.5.2.4.1 Japan: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.3.5.2.5 Japan: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.3.5.3 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.3.1 Overview
        • 10.3.5.3.2 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.3.3 India: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.3.5.3.4 India: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.3.5.3.4.1 India: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.3.5.3.5 India: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.3.5.4 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.4.1 Overview
        • 10.3.5.4.2 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.4.3 Australia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.3.5.4.4 Australia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.3.5.4.4.1 Australia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.3.5.4.5 Australia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.3.5.5 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.5.1 Overview
        • 10.3.5.5.2 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.5.3 South Korea: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.3.5.5.4 South Korea: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.3.5.5.4.1 South Korea: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.3.5.5.5 South Korea: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.3.5.6 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.6.1 Overview
        • 10.3.5.6.2 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.6.3 Rest of Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.3.5.6.4 Rest of Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.3.5.6.4.1 Rest of Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.3.5.6.5 Rest of Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  • 10.4 Middle East & Africa: Endothelial Dysfunction Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.4.3 Middle East & Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    • 10.4.4 Middle East & Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
      • 10.4.4.1 Middle East & Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    • 10.4.5 Middle East & Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.4.5.1 Saudi Arabia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.1.1 Overview
        • 10.4.5.1.2 Saudi Arabia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.1.3 Saudi Arabia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.4.5.1.4 Saudi Arabia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.4.5.1.4.1 Saudi Arabia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.4.5.1.5 Saudi Arabia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.4.5.2 UAE: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.2.1 Overview
        • 10.4.5.2.2 UAE: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.2.3 UAE: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.4.5.2.4 UAE: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.4.5.2.4.1 UAE: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.4.5.2.5 UAE: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.4.5.3 South Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.3.1 Overview
        • 10.4.5.3.2 South Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.3.3 South Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.4.5.3.4 South Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.4.5.3.4.1 South Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.4.5.3.5 South Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.4.5.4 Rest of Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.4.1 Overview
        • 10.4.5.4.2 Rest of Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.4.3 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.4.5.4.4 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.4.5.4.4.1 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.4.5.4.5 Rest of Middle East & Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  • 10.5 South & Central America: Endothelial Dysfunction Market
    • 10.5.1 Overview
    • 10.5.2 South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.5.3 South & Central America: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    • 10.5.4 South & Central America: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
      • 10.5.4.1 South & Central America: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.5 South & Central America: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.5.5.1 Brazil: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.1.1 Overview
        • 10.5.5.1.2 Brazil: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.1.3 Brazil: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.5.5.1.4 Brazil: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.5.5.1.4.1 Brazil: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.1.5 Brazil: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.5.5.2 Argentina: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.2.1 Overview
        • 10.5.5.2.2 Argentina: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.2.3 Argentina: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.5.5.2.4 Argentina: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.5.5.2.4.1 Argentina: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.2.5 Argentina: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.5.5.3 Rest of South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.3.1 Overview
        • 10.5.5.3.2 Rest of South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.3.3 Rest of South & Central America: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.5.5.3.4 Rest of South & Central America: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.5.5.3.4.1 Rest of South & Central America: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.3.5 Rest of South & Central America: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Endothelial Dysfunction Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 South & Central America: Impact Assessment of COVID-19 Pandemic
  • 11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12. Endothelial Dysfunction Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Endothelial Dysfunction Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 ZOLL Medical Corp
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Sphingo Tec GmbH
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Lawrence Berkeley National Laboratory
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 The Polymath Co
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Endothelix Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Perimed AB
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 SMART Medical Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Everist Health Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Alam Medical SaRl
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Medizinische Messtechnik GmbH
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Techniques Used in to Assess Endothelial Function
  • Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
  • Table 3. North America Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. North America Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. North America Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. US Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. US Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. US Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Canada Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Canada Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Canada Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Canada Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Mexico Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Mexico Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Mexico Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Mexico Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Europe Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Europe Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Europe Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Europe Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Germany Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Germany Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Germany Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Germany Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. UK Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. UK Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. UK Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. UK Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. France Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. France Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. France Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. France Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Italy Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Italy Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Italy Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Italy Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. Spain Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Spain Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Spain Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Spain Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Rest of Europe Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. Rest of Europe Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. Rest of Europe Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. Rest of Europe Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. Asia Pacific Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Asia Pacific Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Asia Pacific Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Asia Pacific Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. China Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. China Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. China Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. China Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Japan Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. Japan Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. Japan Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Japan Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. India Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 60. India Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. India Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 62. India Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 63. Australia Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. Australia Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. Australia Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 66. Australia Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. South Korea Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. South Korea Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. South Korea Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 70. South Korea Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. Rest of Asia Pacific Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. Rest of Asia Pacific Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Rest of Asia Pacific Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Rest of Asia Pacific Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Middle East & Africa Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Middle East & Africa Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. Middle East & Africa Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. Middle East & Africa Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Saudi Arabia Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Saudi Arabia Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Saudi Arabia Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Saudi Arabia Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 83. UAE Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 84. UAE Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 85. UAE Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 86. UAE Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 87. South Africa Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 88. South Africa Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 89. South Africa Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 90. South Africa Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 91. Rest of Middle East & Africa Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 92. Rest of Middle East & Africa Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 93. Rest of Middle East & Africa Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 94. Rest of Middle East & Africa Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 95. South & Central America Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 96. South & Central America Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 97. South & Central America Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
  • Table 98. South & Central America Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 99. Brazil Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 100. Brazil Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 101. Brazil Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
  • Table 102. Brazil Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 103. Argentina Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 104. Argentina Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 105. Argentina Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
  • Table 106. Argentina Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 107. Rest of South & Central America Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 108. Rest of South & Central America Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 109. Rest of South & Central America Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
  • Table 110. Rest of South & Central America Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 111. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
  • Table 112. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
  • Table 113. Glossary of Terms, Endothelial dysfunction market

List Of Figures

  • Figure 1. Endothelial Dysfunction Market Segmentation
  • Figure 2. Endothelial Dysfunction Market by Region
  • Figure 3. Global Endothelial Dysfunction Market Overview
  • Figure 4. Hypertension Account for Largest Share of Cause Segment in Endothelial Dysfunction Market
  • Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Endothelial Dysfunction Market, by Geography (US$ Million)
  • Figure 7. Global Endothelial Dysfunction Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Endothelial Dysfunction Market - Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South and Central America: PEST Analysis
  • Figure 14. Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
  • Figure 15. Global Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 16. Global Endothelial Dysfunction Market, by Geography - Forecast and Analysis (2022-2028)
  • Figure 17. Market Positioning of Key Players in the Endothelial Dysfunction Market
  • Figure 18. Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
  • Figure 19. Hypertension: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Diabetes: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Hypercholestrolaemia: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Behcet's disease: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Obesity: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
  • Figure 26. Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Non-Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Flow Mediated Dilatory: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Venous Occlusion Plethysmography: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Peripheral Arterial Tonometry (PAT): Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Circulating Markers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
  • Figure 34. Hospitals and Clinics: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Diagnostics Centers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Clinics: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. North America: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 39. North America Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. North America: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
  • Figure 41. US: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Europe: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 45. Europe Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Europe: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
  • Figure 47. Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. UK: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. France: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Asia Pacific: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 54. Asia Pacific Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 55. Asia Pacific: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
  • Figure 56. China: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. India: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Middle East & Africa: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 63. Middle East & Africa Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Middle East & Africa: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
  • Figure 65. Saudi Arabia: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. UAE: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. South Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. Rest of Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. South & Central America: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 70. South & Central America Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. South & Central America: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
  • Figure 72. Brazil: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 73. Argentina: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 74. Rest of South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 75. Impact of COVID-19 Pandemic on North American Countries Markets
  • Figure 76. Impact of COVID-19 Pandemic on European Countries Markets
  • Figure 77. Impact of COVID-19 Pandemic on Asia Pacific Countries Markets
  • Figure 78. Impact of COVID-19 Pandemic on South & Central American Countries Markets
  • Figure 79. Impact of COVID-19 Pandemic on Middle East & African Countries Markets
  • Figure 80. Growth Strategies in the Endothelial Dysfunction Market